Guidelines Favor taTME Over Laparoscopic Techniques for Rectal Cancer
taTME offers a preferred option for treating low- and selected mid-rectal cancers in appropriate surgical settings.
Newsletter
Every new paper in this field, in your inbox.
taTME offers a preferred option for treating low- and selected mid-rectal cancers in appropriate surgical settings.
Watch-and-wait management is viable for rectal cancers not palpable on exam, keeping patient outcomes comparable.
Colorectal cancer (CRC) incidence and mortality are sharply increasing in East Asia, necessitating targeted surgical interventions and screening.
Selected rectal cancer patients can safely skip neoadjuvant therapy and proceed directly to total mesorectal excision.
Resection significantly lowers recurrence in sigmoid volvulus but comes with increased mortality risks.
Chanling Gao shows promise in managing liver metastasis from colorectal cancer, a major mortality factor in CRC, opening doors for enhanced treatment strategies.
Prune consumption significantly lowers the risk of low anterior resection syndrome (LARS) after surgery.
Patients with blunt intestinal injuries benefit from surgery in high-volume trauma centers, reducing delays and complications.
A new ctDNA methylation-based model shows promise for preoperatively identifying lymph node metastasis in colorectal cancer, influencing surgical decisions.
Laser hair treatment significantly reduces recurrence of pilonidal disease in adolescents and young adults but its effectiveness varies by insurance type.